Researchers at Fred Hutchinson Cancer Research Center showed about 70 percent of patients with the most common adult leukemia had their tumors shrink or disappear following an experimental chimeric antigen receptor (CAR) T-cell immunotherapy. The...
14-Jul-2017 2:05 PM EDT Add to Favorites
Fred Hutchinson Cancer Research Center’s board of trustees yesterday elected three new members, adding expertise in information technology, media and global health as it works to accelerate efforts to develop cures for cancer and other diseases.
29-Jun-2017 2:30 PM EDT Add to Favorites
Fred Hutch Scientists to Develop Bioassay for Ovarian Cancer for New National Cancer Institute Initiative
Dr. Amanda Paulovich of Fred Hutch will lead a multi-institution effort to develop a biological test to predict which treatments will work for patients with ovarian cancer. Photos, video available:...
27-Jun-2017 11:05 AM EDT Add to Favorites
A Fred Hutchinson Cancer Research Center study, led by epidemiologist Dr. Parveen Bhatti, found that night shift work is associated with reduced ability to repair DNA lesions. Over time, DNA damage that is not repaired will cause mutations that can...
26-Jun-2017 6:30 PM EDT Add to Favorites
Among long-term colorectal cancer survivors, use of nonsteroidal anti-inflammatory drugs, or NSAIDs, is associated with about a 25 percent reduction in all-cause mortality, according to new research from Fred Hutchinson Cancer Research Center.
13-Jun-2017 7:05 PM EDT Add to Favorites
SWOG Clinical Trials Added More Than 3M Years of Life for Cancer Patients, Fred Hutch Researcher Reports
For an investment of $125 for each year of life gained since the 1950s, the National Cancer Institute-funded SWOG clinical trials program has added 3.34 million years of life for cancer patients in the United States because of successful therapies...
1-Jun-2017 12:45 PM EDT Add to Favorites
The critical component of an experimental vaccine led to an escalating immune response in patients with sarcoma, an indicator of its potential anti-cancer effects. The findings will be presented by Dr. Seth Pollack, a physician-scientist at Fred...
1-Jun-2017 7:05 PM EDT Add to Favorites
By adding an experimental drug to a standard chemotherapy regimen, a subset of patients with metastatic pancreatic cancer had a significantly longer period before the cancer progressed as compared with those who received the standard treatment,...
31-May-2017 2:05 PM EDT Add to Favorites
Fred Hutch Glioblastoma Experts Available to Discuss Diagnosis, Treatment Options and the Latest Research
20-Jul-2017 5:05 PM EDT
Embargoed Research: In Fred Hutch Study, Obese Women Who Lost Weight Significantly Lowered Levels of Proteins in the Blood That Help Certain Tumors Grow
12-Jul-2016 12:05 AM EDT
15-Jun-2016 6:05 PM EDT
Fred Hutch Expert Available to Discuss NEJM Article on Biomarker Tests for Molecularly Targeted Therapies
Gary H. Lyman, MD, MPH, an internationally recognized oncologist and health economist at Fred Hutchinson Cancer Research Center and a member of a committee of the National Academies of Sciences, Engineering, and Medicine (NASEM), is available to...
14-Jun-2016 1:05 AM EDT
If you’re seeking an expert to discuss a new study (in Nature) about the future of personalized breast cancer treatment, Dr. Amanda (Mandy) Paulovich, Oncologist and Geneticist at Fred Hutchinson Cancer Research Center and one of the study’s...
25-May-2016 1:05 PM EDT
Experimental HIV Vaccine Regimen to Be Tested in Large-Scale Clinical Trial; Could Lead to First Licensed AIDS Vaccine.
18-May-2016 7:05 PM EDT
#Exercise and #Cancer Risk: @Fredhutch Expert Can Comment on Study in Today's JAMA Internal Medicine
16-May-2016 12:05 PM EDT
Cancer and Mental Health Disorders: @FredHutch Survivorship Expert Available to Discuss New Findings
28-Apr-2016 12:05 PM EDT